BR100 Decreased By (-1.23%)
BR30 Decreased By (-1.32%)
KSE100 Decreased By (-1%)
KSE30 Decreased By (-1.1%)
AGHA 7.72 Decreased By ▼ -0.09 (-1.15%)
BECO 5.14 Decreased By ▼ -0.07 (-1.34%)
BML 57.00 Decreased By ▼ -0.50 (-0.87%)
BOP 33.89 Decreased By ▼ -0.14 (-0.41%)
CNERGY 9.87 Decreased By ▼ -0.09 (-0.9%)
CSIL 5.29 Decreased By ▼ -0.02 (-0.38%)
FCCL 52.88 Decreased By ▼ -1.82 (-3.33%)
FFL 16.53 Decreased By ▼ -0.16 (-0.96%)
FNEL 1.22 Decreased By ▼ -0.01 (-0.81%)
KEL 7.22 Decreased By ▼ -0.18 (-2.43%)
KOSM 5.75 Decreased By ▼ -0.02 (-0.35%)
LOTCHEM 29.10 Decreased By ▼ -0.22 (-0.75%)
MLCF 91.90 Decreased By ▼ -2.46 (-2.61%)
NBP 201.03 Decreased By ▼ -2.02 (-0.99%)
NCPL 56.32 Decreased By ▼ -0.68 (-1.19%)
NPL 66.69 Decreased By ▼ -1.01 (-1.49%)
OGDC 313.50 Decreased By ▼ -2.34 (-0.74%)
PACE 10.47 Decreased By ▼ -0.17 (-1.6%)
PAEL 41.98 Decreased By ▼ -1.22 (-2.82%)
PIBTL 16.45 Decreased By ▼ -0.29 (-1.73%)
PPL 215.46 Decreased By ▼ -4.32 (-1.97%)
PRL 50.30 Increased By ▲ 1.11 (2.26%)
PTC 69.88 Decreased By ▼ -0.65 (-0.92%)
SSGC 27.00 Decreased By ▼ -1.25 (-4.42%)
TBL 9.80 Decreased By ▼ -0.06 (-0.61%)
TELE 8.65 Decreased By ▼ -0.14 (-1.59%)
TPL 18.16 Decreased By ▼ -0.08 (-0.44%)
TPLP 13.46 Increased By ▲ 0.19 (1.43%)
TREET 22.50 Decreased By ▼ -0.22 (-0.97%)
TRG 59.26 Decreased By ▼ -0.88 (-1.46%)
Business & Finance

Dubai to roll out China's Sinopharm COVID-19 vaccine on Sunday

  • All Emirati nationals are eligible for the vaccine. Senior residents could also benefit from the campaign.
  • Dubai began the first phase of the vaccination campaign in December with the COVID-19 vaccine produced by Pfizer and BioNTech.
Published Updated
By

DUBAI: Dubai said on Saturday it will roll out China's Sinopharm vaccine to the general public as coronavirus infections surge in the Middle East tourism hub.

The Sinopharm campaign will start on Sunday, the Dubai media office said in a statement, adding all Emirati nationals are eligible for the vaccine. Senior residents could also benefit from the campaign, it added.

Dubai began the first phase of the vaccination campaign in December with the COVID-19 vaccine produced by Pfizer and BioNTech.

Comments

Comments are closed for this article.